Antisense therapy

A new approach to killing C. difficile, the most common hospital-acquired bacterial infection in the US, is called antisense therapy. This approach allows the drug to kill only C. difficile unlike many antibiotics that kill both good and bad bacteria. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.